Atlas Trials

Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations

Clinical trial NCT07664839 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07664839
Sponsor
Shen yang
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaNPM1 MutationIDH1 MutationIDH2 Mutation
Start date
2026-07-01
Primary completion
2028-05-31
Enrollment
148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.